Literature DB >> 15678312

Identifying infants at risk of marked thyroid suppression post-cardiopulmonary bypass.

Kevin Plumpton1, Nikolaus A Haas.   

Abstract

OBJECTIVE: The clinical benefit of tri-iodothyrinone (T(3)) replacement following congenital heart surgery with cardiopulmonary bypass (CPB) is not clear in unselected cohorts of children. Infants with more marked thyroid hormone suppression or prolonged post-CPB recovery may benefit from T(3) replacement. This study aimed to identify infants at risk of more marked suppression by examining the relationship between organ support parameters during CPB and post-operative thyroid hormone levels. DESIGN AND
SETTING: Prospective observational study in a tertiary referral centre for congenital heart surgery. PATIENTS: 36 infants less than 12 months of age were recruited following CPB. MEASUREMENTS AND
RESULTS: Thyroid hormone levels were measured on admission to the intensive care unit and on post-operative days 1 and 2. Increasing CPB time was associated with decreasing admission free T(3) and thyroid-stimulating hormone. Younger, smaller infants had lower admission levels of free T(3) on univariant analysis. Infants who continued to require ventilation 48 h after admission to the ICU had a mean free T(3) level on post-operative day 2 that was 0.9 pmol/l lower than in those who had been extubated.
CONCLUSIONS: Prospective studies of T(3) replacement in selected young infants (less than 3 months) with long CPB time (greater than 120 min) during congenital heart surgery are warranted.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15678312     DOI: 10.1007/s00134-004-2549-1

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  30 in total

1.  Thyroid hormones levels in infants during and after cardiopulmonary bypass with ultrafiltration.

Authors:  R Bartkowski; M Wojtalik; E Korman; G Sharma; J Henschke; W Mrówczyński
Journal:  Eur J Cardiothorac Surg       Date:  2002-12       Impact factor: 4.191

Review 2.  Dangerous dogmas in medicine: the nonthyroidal illness syndrome.

Authors:  L J De Groot
Journal:  J Clin Endocrinol Metab       Date:  1999-01       Impact factor: 5.958

3.  Thyroid hormone metabolism and level of illness severity in pediatric cardiac surgery patients.

Authors:  D B Allen; K A Dietrich; J J Zimmerman
Journal:  J Pediatr       Date:  1989-01       Impact factor: 4.406

4.  Thyroid function in infants following cardiac surgery: comparative effects of iodinated and noniodinated topical antiseptics.

Authors:  T V Brogan; S L Bratton; A M Lynn
Journal:  Crit Care Med       Date:  1997-09       Impact factor: 7.598

5.  Altered thyroid function in nonthyroidal illness and surgery. To treat or not to treat?

Authors:  R D Utiger
Journal:  N Engl J Med       Date:  1995-12-07       Impact factor: 91.245

Review 6.  Clinical review 86: Euthyroid sick syndrome: is it a misnomer?

Authors:  I J Chopra
Journal:  J Clin Endocrinol Metab       Date:  1997-02       Impact factor: 5.958

7.  Thyroid hormone treatment after coronary-artery bypass surgery.

Authors:  J D Klemperer; I Klein; M Gomez; R E Helm; K Ojamaa; S J Thomas; O W Isom; K Krieger
Journal:  N Engl J Med       Date:  1995-12-07       Impact factor: 91.245

8.  Interleukin-6 and thyroid hormone metabolism in pediatric cardiac surgery patients.

Authors:  Clarie K McMahon; Irwin Klein; Kaie Ojamaa
Journal:  Thyroid       Date:  2003-03       Impact factor: 6.568

9.  Prevalence and clinical implications of abnormal thyroid hormone metabolism in advanced heart failure.

Authors:  M A Hamilton
Journal:  Ann Thorac Surg       Date:  1993-07       Impact factor: 4.330

10.  Pulmonary effects of triiodothyronine (T3) and hydrocortisone (HC) supplementation in preterm infants less than 30 weeks gestation: results of the THORN trial--thyroid hormone replacement in neonates.

Authors:  Sumita Biswas; June Buffery; Helen Enoch; Martin Bland; Michael Markiewicz; Dafydd Walters
Journal:  Pediatr Res       Date:  2003-01       Impact factor: 3.756

View more
  10 in total

Review 1.  Year in review in intensive care medicine, 2005. III. Nutrition, pediatric and neonatal critical care, and experimental.

Authors:  Peter Andrews; Elie Azoulay; Massimo Antonelli; Laurent Brochard; Christian Brun-Buisson; Geoffrey Dobb; Jean-Yves Fagon; Herwig Gerlach; Johan Groeneveld; Jordi Mancebo; Philipp Metnitz; Stefano Nava; Jerome Pugin; Michael Pinsky; Peter Radermacher; Christian Richard; Robert Tasker
Journal:  Intensive Care Med       Date:  2006-02-18       Impact factor: 17.440

2.  Triiodothyronine Supplementation in Infants and Children Undergoing Cardiopulmonary Bypass (TRICC): a multicenter placebo-controlled randomized trial: age analysis.

Authors:  Michael A Portman; April Slee; Aaron K Olson; Gordon Cohen; Tom Karl; Elizabeth Tong; Laura Hastings; Hitendra Patel; Olaf Reinhartz; Antonio R Mott; Richard Mainwaring; Justin Linam; Sara Danzi
Journal:  Circulation       Date:  2010-09-14       Impact factor: 29.690

Review 3.  Nonthyroidal illness syndrome in children.

Authors:  Seth D Marks
Journal:  Endocrine       Date:  2009-09-25       Impact factor: 3.633

4.  Thyroid hormone and cortisol concentrations after congenital heart surgery in infants younger than 3 months of age.

Authors:  Kevin R Plumpton; Brian J Anderson; John Beca
Journal:  Intensive Care Med       Date:  2009-10-07       Impact factor: 17.440

Review 5.  Clinical review: thyroid hormone replacement in children after cardiac surgery--is it worth a try?

Authors:  Nikolaus A Haas; Christoph K Camphausen; Deniz Kececioglu
Journal:  Crit Care       Date:  2006-05-23       Impact factor: 9.097

6.  Predictors of Low Cardiac Output Syndrome in Infants After Open-Heart Surgery.

Authors:  Liang Zou; Di Yu; Ruonan Wang; Yueshuang Cun; Yaping Li; Qingfeng Wang; Yaqin Shu; Xuming Mo
Journal:  Front Pediatr       Date:  2022-03-10       Impact factor: 3.418

7.  Effect of perioperative use of oral triidothyronine for infants undergoing complex congenital cardiac surgeries under cardiopulmonary bypass: A double-blinded randomised controlled study.

Authors:  Sujithareddy Karri; Banashree Mandal; Bhupesh Kumar; Goverdandutt Puri; Shyam Thingnam; Hemant Kumar; V S Unnikrishnan
Journal:  Ann Card Anaesth       Date:  2022 Jul-Sep

8.  Non-thyroidal illness syndrome and cardiopulmonary bypass in children with congenital heart disease.

Authors:  Kazem Babazadeh; Avisa Tabib; Peyman Eshraghi; Hooman Bakhshandeh; Hassan Zamani
Journal:  Caspian J Intern Med       Date:  2014

9.  Preoperative oral thyroid hormones to prevent euthyroid sick syndrome and attenuate myocardial ischemia-reperfusion injury after cardiac surgery with cardiopulmonary bypass in children: A randomized, double-blind, placebo-controlled trial.

Authors:  Jia-Qiang Zhang; Quan-Yong Yang; Fu-Shan Xue; Wei Zhang; Gui-Zhen Yang; Xu Liao; Fan-Min Meng
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.817

Review 10.  The Current Status of Neuroprotection in Congenital Heart Disease.

Authors:  Kei Kobayashi; Christopher Liu; Richard A Jonas; Nobuyuki Ishibashi
Journal:  Children (Basel)       Date:  2021-12-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.